Fabrizio Vernieri

36PUBLICATIONS
104CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Medical molecular engineering of nucleic acids and proteinsEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

|Jun 05, 2026
Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial.

|Mar 27, 2026
OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study.

Danilo Antonio Montisano, Alessandra Parisi, Alberto Raggi

|Mar 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis

Pageof 6

Frequent Collaborators

21 joint publications

Claudia Altamura

11 joint publications

Nicoletta Brunelli

9 joint publications

Raffaele Ornello

9 joint publications

Simona Sacco